Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Mentha Piperita Oil
Therapeutic Area : Urology
Study Phase : Phase I/ Phase II
Sponsor : Integrative Therapeutics
Deal Size : Inapplicable
Deal Type : Inapplicable
Peppermint Oil for the Treatment of Interstitial Cystitis / Bladder Pain Syndrome
Details : Peppermint Oil is a Plant Extract/Herbal drug candidate, which is currently being evaluated in phase I/ phase II clinical studies for the treatment of Cystitis, Interstitial.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
April 14, 2021
Lead Product(s) : Mentha Piperita Oil
Therapeutic Area : Urology
Highest Development Status : Phase I/ Phase II
Sponsor : Integrative Therapeutics
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Mentha Piperita Oil
Therapeutic Area : Neurology
Study Phase : Undisclosed
Sponsor : PROCTER AND GAMBLE
Deal Size : Inapplicable
Deal Type : Inapplicable
Cognitive Effects of Mint Essential Oil
Details : Mentha Piperita is a drug candidate, which is currently being evaluated in clinical studies for the treatment of Cognition Disorders.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
March 23, 2018
Lead Product(s) : Mentha Piperita Oil
Therapeutic Area : Neurology
Highest Development Status : Undisclosed
Sponsor : PROCTER AND GAMBLE
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Mentha Piperita Oil
Therapeutic Area : Gastroenterology
Study Phase : Phase III
Sponsor : ZonMw
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Peppermint Oil is a Plant Extract/Herbal drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Irritable Bowel Syndrome.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
March 23, 2016
Lead Product(s) : Mentha Piperita Oil
Therapeutic Area : Gastroenterology
Highest Development Status : Phase III
Sponsor : ZonMw
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Mentha Piperita Oil
Therapeutic Area : Gastroenterology
Study Phase : Phase II
Sponsor : ZonMw
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Menthae Piperitae Aetheroleum is a drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Irritable Bowel Syndrome.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
November 14, 2014
Lead Product(s) : Mentha Piperita Oil
Therapeutic Area : Gastroenterology
Highest Development Status : Phase II
Sponsor : ZonMw
Deal Size : Inapplicable
Deal Type : Inapplicable